Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

3.53
-0.0500-1.40%
Pre-market: 3.540.0100+0.28%04:30 EDT
Volume:1.26M
Turnover:4.47M
Market Cap:1.10B
PE:35.30
High:3.62
Open:3.57
Low:3.44
Close:3.58
52wk High:11.85
52wk Low:3.42
Shares:313.00M
Float Shares:116.17M
Volume Ratio:2.06
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1000
EPS(LYR):0.1000
ROE:--
ROA:3.60%
PB:-3.88
PE(LYR):35.30

Loading ...

Stock Track | Alvotech Plunges 10.54% After-Hours on Q3 Revenue Miss and Lowered Guidance

Stock Track
·
Nov 13, 2025

UK Court Backs Alvotech in Eylea Biosimilar Manufacturing Dispute

Reuters
·
Nov 13, 2025

Alvotech Q3 EPS $(0.02), Inline, Sales $113.744M Miss $117.203M Estimate

Benzinga
·
Nov 13, 2025

Alvotech Reports $420 Million Revenue and $136.5 Million Net Profit for First Nine Months of 2025

Reuters
·
Nov 13, 2025

Alvotech 9M Net Income USD 136.466 Million

THOMSON REUTERS
·
Nov 13, 2025

Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update

THOMSON REUTERS
·
Nov 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

BRIEF-UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea

Reuters
·
Nov 10, 2025

UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of Avt06, Biosimilar to Eylea® (Aflibercept)

THOMSON REUTERS
·
Nov 10, 2025

Alvotech Wins UK Approval for Eylea Biosimilar AVT06

Reuters
·
Nov 10, 2025

Does Alvotech’s 35% Weekly Drop Reveal a Rare Opportunity for 2025 Investors?

Simply Wall St.
·
Nov 08, 2025

Alvotech’s Gobivaz Biosimilar Gains UK Approval

TIPRANKS
·
Nov 07, 2025

BUZZ-Alvotech rises as UK clears new arthritis drug

Reuters
·
Nov 06, 2025

Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (Golimumab), From the Mhra

THOMSON REUTERS
·
Nov 06, 2025

Alvotech and Advanz Pharma Win UK Approval for Simponi Biosimilar Gobivaz

Reuters
·
Nov 06, 2025

Alvotech SA to Release Financial Results for First Nine Months of 2025

Reuters
·
Nov 05, 2025

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update

GlobeNewswire
·
Nov 05, 2025

Alvotech Shares Fall After Deutsche Bank Downgrade

MT Newswires Live
·
Nov 05, 2025

Deutsche Bank Downgrades Alvotech to Hold From Buy, Cuts Price Target to $8 From $14

MT Newswires Live
·
Nov 04, 2025

Alvotech downgraded to Hold from Buy at Deutsche Bank

TIPRANKS
·
Nov 04, 2025